Report cover image

Bioabsorbable Stents (BAS) Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Publisher GlobalData
Published Apr 19, 2023
Length 105 Pages
SKU # GBDT17954896

Description

Bioabsorbable Stents (BAS) Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Bioabsorbable Stents (BAS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Bioabsorbable Stents (BAS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Bioabsorbable stents are also known as bioreabsorbable or biodegradable coronary stents. The advantage of this stent is that it does not leave any metal body behind and hence, the possibility of late-stent thrombosis and restenosis decreases. Bioabsorbable stents help in better drug delivery compared to metallic stents.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Bioabsorbable Stents (BAS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bioabsorbable Stents (BAS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bioabsorbable Stents (BAS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

105 Pages
  • About GlobalData
    • Bioabsorbable Stents (BAS) Overview
    • Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
    • Bioabsorbable Stents (BAS) - Pipeline Products by Territory
    • Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
    • Bioabsorbable Stents (BAS) - Pipeline Products by Estimated Approval Date
    • Bioabsorbable Stents (BAS) - Ongoing Clinical Trials
    • Bioabsorbable Stents (BAS) Companies - Pipeline Products by Stage of Development
    • Bioabsorbable Stents (BAS) –Companies Pipeline Products by Stage of Development
    • Abbott Vascular Inc Company Overview
    • Amaranth Medical Inc Company Overview
    • Arterius Ltd Company Overview
    • Biosensors International Group Ltd Company Overview
    • Biosten, LLC Company Overview
    • Biotronik AG Company Overview
    • Biotronik SE & Co KG Company Overview
    • Biotyx Medical (Shenzhen) Co Ltd Company Overview
    • Boston Scientific Corp Company Overview
    • Cardionovum GmbH Company Overview
    • Cordis Corp Company Overview
    • HangZhou HuaAn Biotechnology Co., Ltd. Company Overview
    • Icon Interventional Systems, Inc. Company Overview
    • Japan Stent Technology Co., Ltd. Company Overview
    • Kyoto Medical Planning Co Ltd Company Overview
    • Lifetech Scientific (Shenzhen) Co Ltd Company Overview
    • Manli Cardiology Ltd Company Overview
    • Meril Life Sciences Pvt Ltd Company Overview
    • Micell Technologies Inc Company Overview
    • Michigan Technological University Company Overview
    • MicroPort Scientific Corp Company Overview
    • Minvasys SAS Company Overview
    • MIV Therapeutics Inc Company Overview
    • NanoCoeur, Inc. Company Overview
    • North Carolina State University Company Overview
    • Northwestern University Company Overview
    • OrbusNeich Company Overview
    • Pediastent LLC Company Overview
    • QualiMed Innovative Medizinprodukte GmbH Company Overview
    • REVA Medical Inc Company Overview
    • S3V Vascular Technologies Company Overview
    • Shanghai Bio-heart Biological Technology Co Ltd Company Overview
    • Shanghai Healing Medical Instruments Co Ltd Company Overview
    • Tepha Inc Company Overview
    • Tremedics Medical Devices LLC Company Overview
    • UAB Minority Health and Health Equity Research Center Company Overview
    • University of Florida Company Overview
    • University of Strathclyde Company Overview
    • VasoTech Inc. Company Overview
    • Xenogenics Corporation Company Overview
    • Mar 08, 2023: OrbusNeich Announces Record Revenue of US$136.8 Million, Adjusted Net Profit Up 25% to US$26.7 Million
    • Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
    • Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
    • Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022
    • Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
    • Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
    • Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us